U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests
NPRU.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests YouTube Enlarge this image toggle caption Ellume Limited Ellume Limited Updated 5:30 p.m. ET The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus which causes COVID-19 that is available without a prescription. Suzanne Sterns, a spokesperson for Ellume, told NPR the company "will be delivering 100,000 tests per month from the Australian manufacturing facility until the U.S. facility is built. Sponsor Message It's important for federal, state and local governments to help make coronavirus tests more affordable, Slavitt said, adding that "life doesn't change" until tests and vaccines become ubiquitous.